Vaxtex Cotfab FY26 net profit rises to ₹552.55 crore
Vaxtex Cotfab Limited reported a net profit of ₹552.55 crore for FY26, up from ₹88.36 crore in the previous year, with total income rising to ₹1,442.54 crore. The Board approved the audited standalone financial results, and the trading window will reopen on May 28, 2026.
*this image is generated using AI for illustrative purposes only.
Vaxtex Cotfab Limited reported a net profit of ₹552.55 crore for the financial year ended March 31, 2026, a sharp increase from ₹88.36 crore in the prior year. The company’s total income for FY26 rose to ₹1,442.54 crore, compared to ₹638.23 crore in FY25. Revenue from operations for the year stood at ₹1,116.64 crore, up from ₹525.33 crore in the previous year.
For the quarter ended March 31, 2026, the company posted a net profit of ₹78.85 crore. Revenue from operations for the quarter was nil, while other income contributed ₹49.81 crore to the total income. The Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with the Statement of Assets and Liabilities and Statement of Cash Flow.
The financial results were reviewed by the Audit Committee and approved by the Board. Statutory Auditors of the Company carried out the statutory audit. The results were prepared in accordance with India Accounting Standards (Ind AS) prescribed under Section 133 of The Companies Act, 2013. The company operates in a single primary segment, "Trading in Textiles," and thus consolidated results are not applicable.
Financial Performance
The company’s earnings per share (EPS) for the year ended March 31, 2026, was ₹0.30, compared to ₹0.05 in the previous year. For the quarter ended March 31, 2026, the EPS was ₹0.04. Total expenses for the year increased to ₹936.39 crore from ₹597.07 crore in FY25.
| Particulars | Year Ended March 31, 2026 (₹ In Lakhs) | Year Ended March 31, 2025 (₹ In Lakhs) |
|---|---|---|
| Total Income | 1,442.54 | 638.23 |
| Total Expenses | 936.39 | 597.07 |
| Net Profit for the period | 552.55 | 88.36 |
| Basic & Diluted EPS (₹) | 0.30 | 0.05 |
Assets and Liabilities
As of March 31, 2026, the company’s total assets stood at ₹3,682.29 crore, a decrease from ₹4,847.38 crore in the previous year. Total equity increased to ₹2,244.04 crore from ₹1,834.02 crore. Non-current liabilities decreased to ₹184.95 crore from ₹735.35 crore, while current liabilities reduced to ₹1,253.30 crore from ₹2,278.01 crore.
The trading window for dealing in the company’s securities by all Designated Persons and their immediate relatives will reopen from May 28, 2026. The Independent Auditor's Report issued an unmodified opinion on the annual audited standalone financial results.
Historical Stock Returns for Vaxtex Cotfab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.42% | -2.80% | -1.42% | -20.11% | +41.84% | -46.95% |
How will the company sustain its profitability given that Q4 revenue from operations was nil?
What strategic initiatives will be implemented to reduce the significant gap between total income and operating revenue?
Will the company diversify its business model beyond the single 'Trading in Textiles' segment to mitigate risks?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
